BioCentury
ARTICLE | Clinical News

APC 366-A: Began a U.S. Phase I trial

November 7, 1994 8:00 AM UTC

Arris Pharmaceutical Corp. (ARRS), South San Francisco Product: APC 366-A small molecule inhibitor of mast cell tryptase enzyme, a regulator of the inflammatory cascade Indication: Asthma Status: Beg...